Celcuity Inc.
Records under this name other than the patents Celcuity Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Showing 1 to 8 of 8 · Back to Celcuity Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 13/494,618 | Whole Cell Assays and Methods Abandoned Abandoned Jun 11, 2015 | Abandoned | Abandoned Jun 11, 2015 | |
| 15/533,897 | Methods of Measuring Erbb Signaling Pathway Activity to Diagnose and Treat Cancer Patients Abandoned Abandoned Jun 5, 2021 | Abandoned | Abandoned Jun 5, 2021 | |
| 17/193,891 | Whole Cell Assays and Methods Abandoned Abandoned Aug 8, 2026 | Abandoned | Abandoned Aug 8, 2026 | |
| 17/835,208 | Methods of Treating Cancer Patients with Ras Node or RTK Targeted Therapeutic Agents Abandoned Abandoned Jul 11, 2026 | Abandoned | Abandoned Jul 11, 2026 | |
| 19/229,722 | Methods for the Treatment of Cancer Using 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-Dimorpholin-4-YL-1,3,5-Triazin-2-YL)PHENYL]UREA Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/306,599 | Treatment Regimens for Gedatolisib in Hormonally-Driven Disorders Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/539,411 | Methods for the Treatment of Cancer Using 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-Dimorpholin-4-YL-1,3,5-Triazin-2-YL)PHENYL]UREA Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/692,517 | Methods for the Treatment of Cancer Using 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-Dimorpholin-4-YL-1,3,5-Triazin-2-YL)PHENYL]UREA Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |